After brain death, hepatic CCN2 was transiently increased in NASH livers but reduced in non-steatotic livers, leading to the proposal that hepatic CCN2 levels have clinical utility for helping evaluate the severity of steatosis in brain-dead donors whose livers are being considered for transplantation [72]. Here, CCN2 is linked to metabolic dysfunction-associated steatohepatitis.